Pamela Ann Connealy
CIK: 0001796310
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 23, 2026OBIO
Orchestra BioMed Holdings, Inc.
Award(A)Direct17.3K shares- - Aug 7, 2025OBIO
Orchestra BioMed Holdings, Inc.
Award(A)Direct15K shares- - Jun 24, 2025OBIO
Orchestra BioMed Holdings, Inc.
Award(A)Direct12.4K shares- - Mar 31, 2025PYXS
Pyxis Oncology, Inc.
Award(A)DirectStock Option (Right to Buy)
414.2K shares at avg. $0.98- - Dec 23, 2024PYXS
Pyxis Oncology, Inc.
Award(A)DirectStock Option (Right to Buy)
310K shares- - Nov 26, 2024PYXS
Pyxis Oncology, Inc.
Purchase(P)Indirect5.5K shares at avg. $2.00$11K - Nov 26, 2024PYXS
Pyxis Oncology, Inc.
Purchase(P)Indirect83.4K shares at avg. $1.96$163K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 23, 2026 |  OBIO Orchestra BioMed Holdings, Inc. | Award(A) | 17,327 | - | $0 | Direct |
| Aug 7, 2025 | OBIO Orchestra BioMed Holdings, Inc. | Award(A) | 15,000 | - | - | Direct |
| Jun 24, 2025 | OBIO Orchestra BioMed Holdings, Inc. | Award(A) | 12,422 | - | - | Direct |
| Mar 31, 2025 |  PYXS Pyxis Oncology, Inc. | Award(A) Stock Option (Right to Buy) | 414,163 | $0.98 | - | Direct |
| Dec 23, 2024 | PYXS Pyxis Oncology, Inc. | Award(A) Stock Option (Right to Buy) | 310,000 | - | - | Direct |
| Nov 26, 2024 | PYXS Pyxis Oncology, Inc. | Purchase(P) | 5,450 | $2.00 | $10,900 | Indirect |
| Nov 26, 2024 | PYXS Pyxis Oncology, Inc. | Purchase(P) | 83,400 | $1.96 | $163,464 | Indirect |
1-7 of 7 transactions
About Connealy Pamela Ann
Connealy Pamela Ann (SEC CIK 0001796310) files insider reports with the SEC as Director of Orchestra BioMed Holdings, Inc. (OBIO) and CFO & COO of Pyxis Oncology, Inc. (PYXS).
Signal8 holds 6 ownership filings by Connealy Pamela Ann, all Form 4s, filed between Nov 27, 2024 and Jun 25, 2026. Those filings report 7 transactions, from Nov 26, 2024 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Connealy Pamela Ann's filings is in NEW HOPE, PA.
Recent filings by Connealy Pamela Ann
- Jun 23, 2026: Grant or award of OBIO shares (Form 4, code A).
- Aug 7, 2025: Grant or award of OBIO shares (Form 4, code A).
- Jun 24, 2025: Grant or award of OBIO shares (Form 4, code A).
- Mar 31, 2025: Grant or award of PYXS derivative securities (Form 4, code A).
- Dec 23, 2024: Grant or award of PYXS derivative securities (Form 4, code A).
Other insiders filing for Orchestra BioMed Holdings, Inc. (OBIO)
- Sherman Darren
- Hochman David P
- Taylor Andrew Lawrence, Chief Financial Officer
- Aiello Joshua, Principal Accounting Officer
- Pacitti David, Director
- Fain Eric S, Director